Advancing ICP and Developing the Burgener Nebulizer: A Winter Conference Interview with John Burgener, Part 1
At the Winter Conference on Plasma Spectrochemistry, Spectroscopy magazine sat down with John Burgener of Burgener Research Inc. to discuss his career working with mass spectrometers, inductively coupled plasma (ICP), and developing the Burgener nebulizer.
John Burgener is the owner and founder of Burgener Research Inc., a company he founded in 1995 (1). The company’s beginnings originated from Technical Service Laboratories, which was founded by his father John E. Burgener. At the age of 15, Burgener began to assist his father in his business by building mass spectrometers designed for sorting metals by looking at the spectrum of the sample and standard simultaneously. His experience with instrumentation led to him landing several jobs with the University of Toronto, where he had the opportunity to repair instruments and conduct some geophysicist work, before working for his father again by setting up laboratories for geochemical analysis (2).
Burgener was one of the Heritage Lecture speakers at the Winter Conference on Plasma Spectrochemistry, where he talked about his extensive career and how he came to make the Burgener nebulizer, which is what his current company is well-known for (1).
In Part 1 of our conversation with Burgener, he answers the following questions:
- Can you briefly recap the origins of Burgener Research for our audience whom may not been able to attend your talk? (00:16–02:14)
- Can you talk about your experience working with inductively coupled plasma (ICP) in your career? What were the benefits and challenges of using the technique at the time you conducted your work? (02:15–05:11)
References
- Burgener, J. Burgener, J. How Helping My Father Repair and Build Spectrometers Led to ICP Advancements and the Development of the Burgener Nebulizer. Presented at the Winter Conference on Plasma Spectrochemistry, in Tucson, Arizona, on January 15th, 2024.
- Burgener, J. History of John Burgener With an Emphasis on Burgener Research and Burgener Nebulizers. Burgener Research Inc. https://www.burgenerresearch.com/JohnBHistory.html (Accessed January 15, 2024)
The Future of Neurodegenerative Disease Research and the Role of IR Imaging
May 21st 2025In the final part of this three-part interview, Ayanjeet Ghosh of the University of Alabama and Rohit Bhargava of the University of Illinois Urbana-Champaign talk about the key performance metrics they used to evaluate their model, and what the future of neurodegenerative disease research looks like.
Describing Their Two-Step Neural Model: An Interview with Ayanjeet Ghosh and Rohit Bhargava
May 20th 2025In the second part of this three-part interview, Ayanjeet Ghosh of the University of Alabama and Rohit Bhargava of the University of Illinois Urbana-Champaign discuss how machine learning (ML) is used in data analysis and go into more detail about the model they developed in their study.
Analyzing the Protein Secondary Structure in Tissue Specimens
May 19th 2025In the first part of this three-part interview, Ayanjeet Ghosh of the University of Alabama and Rohit Bhargava of the University of Illinois Urbana-Champaign discuss their interest in using discrete frequency infrared (IR) imaging to analyze protein secondary structures.
How Do We Improve Elemental Impurity Analysis in Pharmaceutical Quality Control?
May 16th 2025In this final part of our conversation with Harrington and Seibert, they discuss the main challenges that they encountered in their study and how we can improve elemental impurity analysis in pharmaceutical quality control.
